Rehabilitation Training Games for Children With Amblyopia
Launched by ZHU DIAN · Apr 17, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new and fun way to help children with amblyopia, also known as "lazy eye." Researchers have created a gamified training program designed to make rehabilitation easier and more enjoyable for kids. The goal is to see how well children can use this game to improve their eye condition while also looking at how easy it is to use, how much they enjoy it, and how consistently they stick to the treatment.
To participate in this study, children need to be diagnosed with amblyopia but should not have severe cases or other serious health issues. They should also be able to communicate well and have support from their parents and teachers. If eligible, children will play the game as part of their treatment and help researchers understand if this approach can make a difference in managing amblyopia. The trial is currently recruiting participants aged between 2 and 10 years old, and parental consent is required for all children involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of amblyopia (including refractive amblyopia, strabismic amblyopia and mixed).
- • The child has no significant IQ deficits and has no difficulty communicating with others.
- • The children's teachers and parents gave their informed consent to participate in the experiment. The informed consent form was signed by the parents and is shown in the Appendix.
- Exclusion Criteria:
- • Severe amblyopia.
- • Suffering from other psychological or physical disorders.
- • Parents did not agree to sign the informed consent form or the child was not willing to participate in this experiment.
About Zhu Dian
Zhu Dian is a leading clinical trial sponsor dedicated to advancing medical research and innovation. With a strong commitment to improving patient outcomes, the organization specializes in the development and management of clinical trials across various therapeutic areas. Zhu Dian leverages its expertise in regulatory compliance, data management, and patient recruitment to facilitate efficient and effective trial execution. By fostering collaborative partnerships with healthcare professionals and stakeholders, Zhu Dian aims to accelerate the delivery of groundbreaking treatments to the market, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Dian Zhu, Dr
Principal Investigator
Shanghai Jiao Tong University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported